WR 238605

Known as: WR-238605 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2003
0119902003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The sporontocidal activity of tafenoquine (WR-238605) and artelinic acid was determined against naturally circulating isolates of… (More)
Is this relevant?
1999
1999
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax. Forty-four P. vivax-infected patients were… (More)
Is this relevant?
1998
1998
WR 238605 is an 8-aminoquinoline drug currently under development for prophylaxis and treatment of malaria. Preclinical studies… (More)
Is this relevant?
1997
1997
The compound WR 238605 is a primaquine analog being developed by the U.S. Army as an antimalarial drug. Currently, there is no… (More)
Is this relevant?
1995
1995
The in vitro metabolism of the 8-aminoquinoline, 8-(4-amino-1- methylbutylamino-2,6-dimethoxy-4-methyl-5-(3-trifluromethyl… (More)
Is this relevant?
1992
1992
The gametocytocidal and sporontocidal activity of three 8-aminoquinolines (primaquine, WR-238605, and WR-242511), three… (More)
Is this relevant?
1990
1990
The influence of WR-238605 (8-[(4-amino-1-methyl-butyl) amino]-2,6-dimethoxy-4-methyl-5-[3-tri-fluoromethylphenoxyl] quinoline… (More)
Is this relevant?